C

Caliway Biopharmaceuticals Co Ltd
TWSE:6919

Watchlist Manager
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
Watchlist
Price: 699 TWD -0.43%
Market Cap: 108.1B TWD

Intrinsic Value

The intrinsic value of one Caliway Biopharmaceuticals Co Ltd stock under the Base Case scenario is 437.89 TWD. Compared to the current market price of 699 TWD, Caliway Biopharmaceuticals Co Ltd is Overvalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
437.89 TWD
Overvaluation 37%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
Caliway Biopharmaceuticals Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Caliway Biopharmaceuticals Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Caliway Biopharmaceuticals Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Caliway Biopharmaceuticals Co Ltd
TWSE:6919
TW
Pharmaceuticals
Market Cap
107.5B TWD
IPO
Dec 26, 2022
TW
Pharmaceuticals
Market Cap
107.5B TWD
IPO
Dec 26, 2022
Price
NT$false
EPS
NT$false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Caliway Biopharmaceuticals Co Ltd
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Caliway Biopharmaceuticals Co Ltd

Balance Sheet Decomposition
Caliway Biopharmaceuticals Co Ltd

Current Assets 9.7B
Cash & Short-Term Investments 9.7B
Receivables 5.2m
Other Current Assets 32m
Non-Current Assets 64.5m
PP&E 61.3m
Other Non-Current Assets 3.1m
Efficiency

Free Cash Flow Analysis
Caliway Biopharmaceuticals Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Caliway Biopharmaceuticals Co Ltd

Revenue
44.4m TWD
Cost of Revenue
-13.7m TWD
Gross Profit
30.8m TWD
Operating Expenses
-747.9m TWD
Operating Income
-717.1m TWD
Other Expenses
128.3m TWD
Net Income
-588.8m TWD
Fundamental Scores

Profitability Score
Profitability Due Diligence

Caliway Biopharmaceuticals Co Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

25/100
Profitability
Score

Caliway Biopharmaceuticals Co Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Caliway Biopharmaceuticals Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Caliway Biopharmaceuticals Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Caliway Biopharmaceuticals Co Ltd

Wall Street analysts forecast Caliway Biopharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Caliway Biopharmaceuticals Co Ltd is 1 060.8 TWD with a low forecast of 1 050.4 TWD and a high forecast of 1 092 TWD.

Lowest
Price Target
1 050.4 TWD
50% Upside
Average
Price Target
1 060.8 TWD
52% Upside
Highest
Price Target
1 092 TWD
56% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Caliway Biopharmaceuticals Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Caliway Biopharmaceuticals Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Caliway Biopharmaceuticals Co Ltd stock?

The intrinsic value of one Caliway Biopharmaceuticals Co Ltd stock under the Base Case scenario is 437.89 TWD.

Is Caliway Biopharmaceuticals Co Ltd stock undervalued or overvalued?

Compared to the current market price of 699 TWD, Caliway Biopharmaceuticals Co Ltd is Overvalued by 37%.

Back to Top